Home Page
About Us
Journal History
Free-of-Charge Publication
Abstracting And Indexing
Copyright
Digital Archiving and Preservation Policy
Aims and Scope
Editorial Board
Instructions to Authors
Instructions to Authors
Ethical Policy
Contact Us
Archive
Author Index
Web Site of Urooncology Association
Archive
Author Index
Web Site of Urooncology Association
E-ISSN:2667-4610
Toggle navigation
Home Page
About Us
Journal History
Free-of-Charge Publication
Abstracting And Indexing
Copyright
Digital Archiving and Preservation Policy
Aims and Scope
Editorial Board
Instructions to Authors
Instructions to Authors
Ethical Policy
Contact Us
Review
The developments in paradigm of prostate cancer in recent years
Sertaç Yazıcı
Halil Kızılöz
Haluk Özen
Bull Urooncol 2014; 13: 1-7
Full
Text
Read
PDF
Prognostic factors in renal cancer and prediction models
Ümit Gül
Özgür Yaycıoğlu
Bull Urooncol 2011; 10: 5-10
Full
Text
Read
PDF
Mesane kanseri; Karsinoma İn Situ (CIS)
Polat Türker
Sinan Ekici
Bull Urooncol 2011; 10: 9-12
Full
Text
Read
PDF
Complications of Urinary Diversions and their Treatment
Eyüp Gümüs
Ugur Boylu
Bull Urooncol 2005; 4: 11-15
Full
Text
Read
PDF
BCG suşlarının tedavi edici etkinlik farkı var mı?
Hayrettin Şahin
Bull Urooncol 2011; 10: 18-20
Full
Text
Read
PDF
Treatment of small renal masses: Where we are in 2011
Mutlu Ateş
Mustafa Karalar
Engin Doğantekin
Bull Urooncol 2011; 10: 21-26
Full
Text
Read
PDF
Is intravesical BCG treatment necessary and/or sufficient?
Sinan Ekici
Polat Türker
Bull Urooncol 2013; 12: 22-25
Full
Text
Read
PDF
Does the Future of Prostate Cancer Treatment Lie with Apoptotic Inducers?
Dr. Ece Konaç
Dr. Sinan Sözen
Bull Urooncol 2017; 16: 22-27
DOI: 10.4274/uob.606
Full
Text
Read
PDF
Benign Prostatic Hyperplasia: not recomended in diagnosis and treatment (Implented with in the historical process, but right now that is not recommended and not recommended guidelines)
Şakir Ongün
İlhan Çelebi
Bull Urooncol 2011; 10: 23-26
Full
Text
Read
PDF
Endoscopic treatment of BPH
Ünal Sert
Özcan Kılıç
Bull Urooncol 2011; 10: 30-33
Full
Text
Read
PDF
Re-operation rates and possible causes related to minimally invasive and surgical treatments of Benign Prostatic Hyperplasia
Serdar Toksöz
Hakan Özkardeş
Bull Urooncol 2011; 10: 34-39
Full
Text
Read
PDF
Importance of mycobacteria in treatment of bladder tumor
Esra Büber
Selçuk Keskin
N. Leyla Açan
Bull Urooncol 2012; 11: 41-45
Full
Text
Read
PDF
Active Surveillance: Treatment Modality that Expect Attention for Localized Prostate Cancer
Tayyar Alp Özkan
Özdal Dillioğlugil
Bull Urooncol 2014; 13: 41-45
Full
Text
Read
PDF
Supportive treatment for patient receiving gemsitabine-cisplatine and suggestions for nursing
Yeter Kırdal
Bull Urooncol 2013; 12: 46-49
Full
Text
Read
PDF
Is it possible to predict BCG effectivity in the treatment of superficial bladder cancer? Are there any markers?
Polat Türker
Sinan Ekici
Bull Urooncol 2012; 11: 46-51
Full
Text
Read
PDF
A critical analysis of surgical curative treatments options in localised prostate cancer: open, laparoscopic, and robotassisted radical prostatectomy
Ender Özden
Yakup Bostancı
Yarkın Kamil Yakupoğlu
Bull Urooncol 2011; 10: 47-50
Full
Text
Read
PDF
The role of 5α-reductase inhibitors on prevention and hormonal treatment of prostate cancer
Bülent Öztürk
Tufan Çiçek
Bull Urooncol 2014; 13: 50-53
Full
Text
Read
PDF
Non-Muscle Invasive Bladder Cancer: Diagnosis and Treatment of Highest-Risk Subgroup
Yılören Tanıdır
İlker Tınay
Bull Urooncol 2015; 14: 50-54
DOI: 10.4274/uob.298
Full
Text
Read
PDF
Algorithmic approach to rising PSA after curative prostate cancer treatment
Levent Mert Günay
Şevket Tolga Tombul
Bülent Akdoğan
Bull Urooncol 2011; 10: 51-55
Full
Text
Read
PDF
Is TUR-B operations can be done in the office conditions by using local anesthesia
Tansu Değirmenci
Bülent Günlüsoy
Bull Urooncol 2012; 11: 52-54
Full
Text
Read
PDF
Are radiological imagings useful in diagnosis, treatment and follow-up of Benign Prostatic Hyperplasia?
Umut Gönülalan
Bülent Öztürk
Bull Urooncol 2011; 10: 55-58
Full
Text
Read
PDF
Outstanding variations in the treatment of prostate cancer bone metastases
İbrahim Cüreklibatır
Bull Urooncol 2014; 13: 58-62
Full
Text
Read
PDF
Role of Nanoparticles in the Treatment of Noninvasive Bladder Cancer
Erem Bilensoy
Nazlı Erdoğar
Aydın N. Mungan
Bull Urooncol 2015; 14: 61-66
DOI: 10.4274/uob.246
Full
Text
Read
PDF
Neoadjuvant and adjuvant treatment modalities for prostate cancer
Erkan Erkan
Gökhan Toktaş
Bull Urooncol 2011; 10: 63-69
Full
Text
Read
PDF
The importance of cellular androgenic hormonal mechanisms in treatment and progression of prostate cancer
Bertrand Tombal
Bull Urooncol 2013; 12: 65-70
Full
Text
Read
PDF
A New Era in Metastatic Prostate Cancer: “The Combination of Chemotherapy and Hormonal Treatment as Initial Treatment”
İlker Tinay
Levent Türkeri
Bull Urooncol 2016; 15: 65-68
DOI: 10.4274/uob.434
Full
Text
Read
PDF
Targeted Therapies in Metastatic Bladder Cancer: Has It Been Approved as a Treatment Option Nowadays?
Nil Molinas Mandel
Bull Urooncol 2015; 14: 67-70
DOI: 10.4274/uob.2015.14.001
Full
Text
Read
PDF
What is the evidence-based ideal treatment of clinical locally advanced (cT3) prostate cancer?
Asıf Yıldırım
Erem Kaan Başok
Bull Urooncol 2011; 10: 70-75
Full
Text
Read
PDF
Hormonal treatment of metastatic prostate cancer: Today and future
Hasan Soydan
Kadir Baykal
Bull Urooncol 2011; 10: 76-81
Full
Text
Read
PDF
Treatment options in low-intermediate risk prostate cancer
Saadettin Yılmaz Eskiçorapçı
Deniz Bolat
Bull Urooncol 2013; 12: 80-85
Full
Text
Read
PDF
Robotic assisted laparoscopic surgery for the treatment of kidney cancer:current status in 2011
Cihan Toktaş
Saadettin Eskiçorapçı
Bull Urooncol 2011; 10: 82-85
Full
Text
Read
PDF
Are there any treatment option for metastatic prostate cancer refractory to docetaksel?
Yaşar Bedük
Bull Urooncol 2011; 10: 85-89
Full
Text
Read
PDF
Which Treatment Should We Prefer for High-Risk Nonmuscle Invasive Bladder Cancer? Early Cystectomy or Bladder Sparing?
Ali Furkan Batur
Sinan Sözen
Bull Urooncol 2014; 13: 93-98
DOI: 10.4274/UOB.07
Full
Text
Read
PDF
Surgical treatment and/or radiotherapy in high risk prostate cancer
Fatih Bıçaklıoğlu
Cenk Acar
Sinan Sözen
Bull Urooncol 2013; 12: 97-101
Full
Text
Read
PDF
Is Lymphadenectomy Necessary in the Surgical Treatment of Upper Urinary Tract Urothelial Carcinoma?
Yakup Kordan
Onur Kaygısız
Bull Urooncol 2014; 13: 99-102
DOI: 10.4274/UOB.08
Full
Text
Read
PDF
The Approach to High Risk Bladder Cancers in The Absence of Bacillus Calmette Guérin: What should Be the Treatment and Follow Up?
Polat Türker
Levent Türkeri
Bull Urooncol 2014; 13: 103-108
DOI: 10.4274/UOB.09
Full
Text
Read
PDF
New treatment options for the castration resistant prostate cancer targeting the androgen synthesis and androgen receptor
Yavuz Selim Süral
Çağ Çal
Bull Urooncol 2013; 12: 106-110
Full
Text
Read
PDF
New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate
Bülent Akdoğan
Bull Urooncol 2013; 12: 111-114
Full
Text
Read
PDF
Radical Prostatectomy and Lymphadenectomy in the High-Risk Prostate Cancer: Surgical Technique, Functional and Oncologic Outcomes
Hayrettin Şahin
Hasan Deliktaş
Bull Urooncol 2015; 14: 113-119
DOI: 10.4274/uob.324
Full
Text
Read
PDF
New treatment options for the castration resistant prostate cancer: Cabazitaxel and Spileucel-T
Gürbüz Görümlü
Erdem Göker
Bull Urooncol 2013; 12: 115-117
Full
Text
Read
PDF
New treatment options in castration resistant prostate cancer: denosumab, alpharadin
Hakan Gemalmaz
Bull Urooncol 2013; 12: 118-122
Full
Text
Read
PDF
The Prostatic Urethral Lift Method: A New Minimally Invasive Modality as an Alternative in the Treatment of Benign Prostatic Hyperplasia
Alpaslan Yüksel
Ali Tekin
Bull Urooncol 2016; 15: 119-122
DOI: 10.4274/uob.584
Full
Text
Read
PDF
Treatment Approaches for Nonmetastatic Castration-Resistant Prostate Cancer
Mehmet Yıldızhan
Hakan Gemalmaz
Mehmet Şirin Ertek
Bull Urooncol 2015; 14: 120-127
DOI: 10.4274/uob.328
Full
Text
Read
PDF
Current Status of Laparoscopic Radical Nephroureterectomy in the Treatment Modalities for Upper Urinary Tract Tumors
Ahmet Güdeloğlu
Cenk Yücel Bilen
Bull Urooncol 2014; 13: 122-126
DOI: 10.4274/UOB.13
Full
Text
Read
PDF
How shoud PSA repalse (rising PSA) be managed after radical prostatectomy? How should treatment algorithms be shaped?
İlker Çelen
Murat Lekili
Bull Urooncol 2013; 12: 127-131
Full
Text
Read
PDF
Active Surveillance in Prostate Cancer
Volkan İzol
Nebil Akdoğan
Bull Urooncol 2017; 16: 127-132
DOI: 10.4274/uob.820
Full
Text
Read
PDF
Current treatment approaches in locally advanced prostate cancer: a radiation oncologist perspective
Ömür Karakoyun Çelik
Bull Urooncol 2012; 11: 129-133
Full
Text
Read
PDF
Radical prostatectomy indications and outcomes in the high-risk localised prostate cancer
Hayrettin Şahin
Hasan Deliktaş
Bull Urooncol 2013; 12: 132-136
Full
Text
Read
PDF
Management of recurrences after radiation therapy used for curative intent in prostate cancer
Yılören Tanıdır
Levent Türkeri
Bull Urooncol 2012; 11: 134-141
Full
Text
Read
PDF
Prostate cancer in the era of robotic surgery
Çag Çal
Bull Urooncol 2012; 11: 150-155
Full
Text
Read
PDF
‘Nanotechnology Applications’ in the Treatment of Prostate Cancer
Ali Furkan Batur
Kerem Gencer Kutman
Mustafa Suat Bolat
Bull Urooncol 2015; 14: 150-155
DOI: 10.4274/uob.375
Full
Text
Read
PDF
Current Treatment of Testicular Sex Cord-Stromal Tumors
Şahin Kabay
Mithat Ekici
Bull Urooncol 2014; 13: 153-156
DOI: 10.4274/uob.100
Full
Text
Read
PDF
Immunotherapy for the treatment of castration resistant prostate cancer: sipuleucel-T
Güven Aslan
Bull Urooncol 2012; 11: 156-158
Full
Text
Read
PDF
Active Surveillance-Factors Affecting the Treatment Decision: 3M: “Marker”, “Mapping”, “MRI”
Ender Özden
Mehmet Necmettin Mercimek
Bull Urooncol 2015; 14: 156-160
DOI: 10.4274/uob.379
Full
Text
Read
PDF
New treatment stragies in metastatic castration resistant prostate cancer: Re-Docetaxel, Abiraterone asetate, Cabazitaxel, MDV 3100
Sıtkı Ün
Ferruh Zorlu
Bull Urooncol 2012; 11: 159-163
Full
Text
Read
PDF
Surgical Approach to the Patients with Positive Surgical Margin after Nephron Sparing Surgery
Bülent Günlüsoy
Yasin Ceylan
Tansu Değirmenci
Bull Urooncol 2014; 13: 165-168
DOI: 10.4274/uob.124
Full
Text
Read
PDF
Current situation of the clinical stage I nonseminomatous germ cell testis tumour
Alim Koşar
Osman Ergün
Bull Urooncol 2012; 11: 181-184
Full
Text
Read
PDF
Molecular Fundamentals of the Revolution in the Treatment of Renal Cell Carcinoma
Ece Konaç
Sinan Sözen
Bull Urooncol 2015; 14: 181-187
DOI: 10.4274/uob.312
Full
Text
Read
PDF
Follow-up principles after curative treatment in renal cancer
Ercan Kazan
Hakan Gemalmaz
Bull Urooncol 2013; 12: 194-200
Full
Text
Read
PDF
Liquid Biopsy: Circulating Tumor Cells and its Impact on Follow-up/Treatment of Prostate Cancer Patients
İbrahim Kulaç
Bull Urooncol 2014; 13: 196-200
DOI: 10.4274/uob.159
Full
Text
Read
PDF
The Diagnosis and Treatment of Retroperitoneal Mass
Ümit Gül
Bull Urooncol 2015; 14: 196-202
DOI: 10.4274/uob.419
Full
Text
Read
PDF
Interventional Treatment of Benign Prostatic Hyperplasia on Elderly People: Prostatic Stent and Prostatic Arterial Embolization
Eray Hasırcı
Mehmet İlteriş Tekin
Bull Urooncol 2014; 13: 210-214
DOI: 10.4274/uob.166
Full
Text
Read
PDF
Active surveillence in small kidney tumors
Yasin Ceylan
Bülent Günlüsoy
Bull Urooncol 2012; 11: 212-215
Full
Text
Read
PDF
Cytoreductive Nephrectomy in the Targeted Treatment Era
Özgür Yaycioglu
Bull Urooncol 2015; 14: 214-218
DOI: 10.4274/uob.435
Full
Text
Read
PDF
Should the treatment approach be different for incidental renal tumors? Turkey databases
Emre Huri
Bull Urooncol 2012; 11: 216-220
Full
Text
Read
PDF
Management of Upper Urinary Tract Tumors: Comparative Oncological Evaluation of Radical Nephroureterectomy and Nephron Sparing Endoscopic Treatments
Ali Tekin
Alpaslan Yüksel
Bull Urooncol 2015; 14: 223-227
DOI: 10.4274/uob.430
Full
Text
Read
PDF
Open partial nephrectomy: recent situation
İyimser Üre
Sinan Sözen
Bull Urooncol 2012; 11: 225-229
Full
Text
Read
PDF
Molecular Biology in Diagnosis and Treatment of Prostate Cancer
Ece Konaç
Sinan Sözen
Bull Urooncol 2014; 13: 228-235
DOI: 10.4274/uob.194
Full
Text
Read
PDF
The Treatment Modalities in Stage 1 Seminoma; Alterations in Last Five Years
Baris Kuzgunbay
Bull Urooncol 2015; 14: 228-231
DOI: 10.4274/uob.389
Full
Text
Read
PDF
Could We Reach the Standard Treatment of Lower Urinary Tract Symptoms/Benign Prostate Hyperplasia?
Eray Hasırcı
Murat Koşan
Bull Urooncol 2014; 13: 247-251
DOI: 10.4274/uob.219
Full
Text
Read
PDF
Minimally invasive treatments for upper urinary tract transitional epithelial carcinoma
Mehmet Selçuk Keskin
Bull Urooncol 2012; 11: 252-255
Full
Text
Read
PDF
Diagnostic and Prognostic Molecular Features of Urothelial Bladder Cancer and New Treatment Approaches
Zafer Küçükodacı
Kutsal Yörükoğlu
Bull Urooncol 2015; 14: 258-270
DOI: 10.4274/uob.366
Full
Text
Read
PDF
Surgical Treatment Options for High Risk Patients with Benign Prostatic Hyperplasia
Eray Hasırcı
Ayhan Dirim
Hakan Özkardeş
Bull Urooncol 2015; 14: 290-295
DOI: 10.4274/uob.482
Full
Text
Read
PDF
The Role of Enflammation as an Etiopathogenetic Mechanism and Treatment Target in Benign Prostatic Hyperplasia
Ali Tekin
Alpaslan Yüksel
Bull Urooncol 2015; 14: 303-307
DOI: 10.4274/uob.258
Full
Text
Read
PDF
The Effects of Medical Treatments Used for Benign Prostatic Hyperplasia on Ejaculation
Ali Kayıkçı
Coşkun Kaçağan
Ali Tekin
Bull Urooncol 2015; 14: 308-311
DOI: 10.4274/uob.277
Full
Text
Read
PDF
Alpha Blocker Treatment and Intra-operative Floppy Iris Syndrome
Mehmet Emin Özyalvaçlı
Ümit Doğan
Adnan Gücük
Bull Urooncol 2015; 14: 312-316
DOI: 10.4274/uob.454
Full
Text
Read
PDF
Quality of Life of Patients with Advanced/Metastatic Renal Cell Carcinoma During the Treatment Period with Targeted Drugs
Sinharib Çitgez
Bull Urooncol 2015; 14: 321-323
DOI: 10.4274/uob.460
Full
Text
Read
PDF
Article - Comment
Treatment delay and prognosis in invasive bladder cancer
Sertaç Yazici
Bull Urooncol 2006; 5: 21-22
Full
Text
Read
PDF
Treatment of testicular cancer: Influence on pituitary-gonadal axis and sexual function
Ali Ihsan Arik
Bull Urooncol 2006; 5: 23-24
Full
Text
Read
PDF
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial
Ali Tekin
Bull Urooncol 2006; 5: 25-26
Full
Text
Read
PDF
Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794
Sefik Igdem
Bull Urooncol 2007; 6: 30-32
Full
Text
Read
PDF
Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate
Yildirim Bayazit
Bull Urooncol 2006; 5: 31-33
Full
Text
Read
PDF
Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy—a propensity scoring approach
Cemil Uygur
Bull Urooncol 2007; 6: 32-33
Full
Text
Read
PDF
Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer
Recep Büyükalpelli
Bull Urooncol 2007; 6: 36-40
Full
Text
Read
PDF
Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic Prostate Cancer
Ali F. Şahin
Bull Urooncol 2012; 11: 178-180
Full
Text
Read
PDF
Quality Of Life
Association of the Benign Prostatic Hyperplasia and erectile dysfunction, the current treatment modalities in Benign Prostatic Hyperplasia
Volkan Şen
Ömer Demir
Ahmet Adil Esen
Bull Urooncol 2011; 10: 62-64
Full
Text
Read
PDF
Male lower urinary tract symptoms: An update – overactive bladder or not ?
Tufan Tarcan
İlker Tınay
Bull Urooncol 2011; 10: 65-69
Full
Text
Read
PDF
Causes and treatment of postprostatectomy incontinence
Bedreddin Seçkin
Özcan Kılıç
Bull Urooncol 2011; 10: 70-73
Full
Text
Read
PDF
BPH: The actual case and the future
Cüneyt İşeri
Bull Urooncol 2011; 10: 74-75
Full
Text
Read
PDF
Can we prevent erectile dysfunction following radical prostatectomy? What are the medical and surgical alternatives?
Cem Akbal
Ferruh Şimsek
Bull Urooncol 2011; 10: 112-116
Full
Text
Read
PDF
The comparison of the treatment alternatives on quality of life in testicular cancers
Sinharib Çitgez
Çetin Demirdağ
Kamil Çam
Bull Urooncol 2013; 12: 271-275
Full
Text
Read
PDF
Radiation Oncology
Radiation therapy for bladder cancer
Ömür Karakoyun Çelik
Fatma Sert
Bull Urooncol 2012; 11: 70-73
Full
Text
Read
PDF
Bph
Prostatic inflammation as a target of etiopathogenesis and treatment
Murat Koşan
Umut Gönülalan
Bull Urooncol 2013; 12: 247-250
Full
Text
Read
PDF
Will lasers replace transurethral resection of the prostate for the treatment of BPH?
Ali Erol
Serhat Dönmezer
Erem Kaan Başok
Bull Urooncol 2013; 12: 255-262
Full
Text
Read
PDF
How can LUTS can be treated in BPH patients with high morbidity?
Uğur Yücetaş
Gökhan Tokdaş
Bull Urooncol 2012; 11: 261-264
Full
Text
Read
PDF
Long-term treatment of Benign Prostatic Hyperplasia with the combination of alpha blockers and 5-alpha reductase inhibitors
Cevahir Özer
Mehmet İlteriş Tekin
Bull Urooncol 2013; 12: 263-266
Full
Text
Read
PDF
Monopolar and bipolar transurethral prostate resection in surgical treatment of benign prostatic hyperplasia
Eray Hasırcı
Ayhan Dirim
Bull Urooncol 2012; 11: 265-269
Full
Text
Read
PDF
Antimuscarinics in the treatment of overactive bladder: does one fit all? Can treatment be individualized?
Ceyhun Özyurt
Bull Urooncol 2012; 11: 275-278
Full
Text
Read
PDF
1
2
3
»
Advanced Search
About Journal
Forms
Useful Links
Subscribe
×
×
Subscribe
Full Name
E-mail